SavedAdd your journal

Journals / Eurasian Journal of Emergency Medicine / 2019 / Cilt: 18 - Sayı: 4

The Predictive Value of Procalcitonin in the Prognosis of Patients with Acute Coronary Syndrome

Şevki Hakan EREN
Abuzer COŞKUN
Can AKTAŞ
Pages
185–191
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ischemic heart failure was found to be statistically higher in anteriorsubgroup than the other subgroups.Conclusion: Increased PCT level may be a marker that can be used in indicating ACS and its prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The study aimed to investigate the prognostic value of serum procalcitonin (PCT) levels in patients with acute coronary syndrome(ACS).Materials and Methods: Two hundred patients with ACS who applied to the emergency department due to chest pain and were hospitalizedinto the cardiology clinic of our hospital between January 2014 and December 2016 were included in this cross-sectional cohort study.
📊
Key Findings & Data:These groupswere compared according to PCT, age, gender, left ventricular ejection fraction, cardiac troponin (cTn) I, three-vessel disease (TVD), andmortality rate.Results: There were statistically significant differences between ACS groups concerning PCT values.
💡
Conclusion & Impact:Ischemic heart failure was found to be statistically higher in anteriorsubgroup than the other subgroups.Conclusion: Increased PCT level may be a marker that can be used in indicating ACS and its prognosis.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The study aimed to investigate the prognostic value of serum procalcitonin (PCT) levels in patients with acute coronary syndrome(ACS).Materials and Methods: Two hundred patients with ACS who applied to the emergency department due to chest pain and were hospitalizedinto the cardiology clinic of our hospital between January 2014 and December 2016 were included in this cross-sectional cohort study. Thepatients were divided into four groups based on their diagnosis. The first group was inferior myocardial infarction (MI), the second groupwas anterior MI, the third group was non-ST-elevation MI (NSTEMI), and the fourth group was high-risk unstable angina (UA). These groupswere compared according to PCT, age, gender, left ventricular ejection fraction, cardiac troponin (cTn) I, three-vessel disease (TVD), andmortality rate.Results: There were statistically significant differences between ACS groups concerning PCT values. PCT level was significantly higher ininferior MI than in anterior MI, NSTEMI, and UA groups. There were statistically significant differences between cTn positivity checkedat 0th, 6th, and 12th hours and ischemic heart failure after MI as well as between mortality and TVD. TVD and mortality were found to besignificantly higher in the inferior MI group than the other subgroups. Ischemic heart failure was found to be statistically higher in anteriorsubgroup than the other subgroups.Conclusion: Increased PCT level may be a marker that can be used in indicating ACS and its prognosis.

🔖

Cite This Article

EREN, Ş. H., COŞKUN, A., AKTAŞ, C. (2022). The Predictive Value of Procalcitonin in the Prognosis of Patients with Acute Coronary Syndrome. Eurasian Journal of Emergency Medicine, Cilt: 18 - Sayı: 4, 185–191. https://ajindex.com/articles/508027

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. World Health Organisation. World healt report, making difference, Geneva WHO 1999
  2. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med. 2001;345:1022-9
  3. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dic J. 2000;19:679-88
  4. Maisner M. Procalcitonin-a new, innovative infection parameter biochemical andclinical aspects
  5. Revised and expanded edition. (Thieme, Stuttgart, New York), 2000
  6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al; American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-74
  7. Sheehan P, Vasikaran SD. The evolving clinical role of cardiac troponins and new acute miyokardial infarction guidelines: Implications for the clinical laboratory. Clin Bichemist Rev. 2001;23:52-65
  8. Wu AHB. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 2001;27:959-61
  9. Morow DA, Rıfai N, Tanasijevic MJ, Wybenga DR, de Lemos JA, Antman EM. Clinical efficasy of three assays for cardiac troponin I for risk stratification in acute coronary syndroms: A trombolysis in myocardial infarction (TIMI) IIB substudy. Clin Chem. 2000;46:453-60
  10. Jaffe AS. A biomarker odyssey. Clin Chim Acta. 1999;284:197-211
  11. Biasucci LM, Biasillo G, Stefanelli A. Procalcitonin and acute coronary syndromes: a new biomarker for an old disease. Intern Emerg Med. 2009;4:363-5
  12. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003
  13. Ataoglu HE, Yilmaz F, Uzunhasan I, Cetin F, Temiz L, Döventaş YE, et al. Procalcitonin: a novel prognostic marker in cardiac disease. J Int Med Res. 2010;38:52-61
  14. Ertem AG, Efe TH, Yayla C, Akboğa MK, Açar B, Ünal S, et al. The Association Between Serum Procalcitonin Le